181 - Friday Q&A: Racial and Ethnic Diversity in the COVID-19 Vaccine Trials

Why is it so important for African-Americans, Hispanic Americans, and other members of racial and ethnic minority groups to participate in COVID-19 vaccine trials? Why is recruitment difficult? How can long standing mistrust of the medical community be mended? What needs to happen to battle myths and inconsistencies that undermine participation?

Dr. Lisa Cooper, director of the Johns Hopkins Center for Health Equity, returns to the podcast with Dr. Josh Sharfstein to answer these and more questions about diversity in COVID-19 vaccines clinical trials.

KEYWORDS: vaccine authorization; racial disparity; misinformation